Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 138 Records) |
| Query Trace: Death and CYP2C19[original query] |
|---|
| Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients. International journal of cardiology 2021 Sep . Al-Rubaish Abdullah M, Al-Muhanna Fahad A, Alshehri Abdullah M, Al-Mansori Mohammed A, Alali Rudaynah A, Khalil Rania M, Al-Faraidy Khalid A, Cyrus Cyril, Sulieman Mohammed M, Vatte Chittibabu, Loza Bao-Li, Claassens Daniel M F, Asselbergs Folkert W, Al-Ali Amein |
| Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention. Pharmacotherapy 2021 Jul . Wood Brian, Lee Craig R, Mulrenin Ian R, Gower Megan N, Rossi Joseph S, Weck Karen E, Stouffer George |
| Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients. Journal of thrombosis and thrombolysis 2021 5 52 (3): 925-933. Muthiah Mark D, Zheng Huili, Chew Nicholas W S, Xiao Jieling, Lim Lee Guan, Tan Huay-Cheem, Lee Chi-Hang, Low Adrian F, Foo Ling-Li, Richards A Mark, Dan Yock-Young, Ho K Y, Yip James W L, Chan Mark |
| Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients. International journal of cardiology 2021 Apr . Claassens Daniel M F, Gimbel Marieke E, Bergmeijer Thomas O, Vos Gerrit J A, Hermanides Renicus S, van der Harst Pim, Barbato Emanuele, Morisco Carmine, Tjon Joe Gin Richard M, de Vrey Evelyn A, Heestermans Ton A C M, Jukema J Wouter, von Birgelen Clemens, Waalewijn Reinier A, Hofma Sjoerd H, den Hartog Frank R, Voskuil Michiel, Van't Hof Arnoud W J, Asselbergs Folkert W, Mosterd A, Herrman Jean-Paul R, Dewilde Willem, Mahmoodi Bakhtawar K, Deneer Vera H M, Ten Berg Jurriën |
| Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China. European journal of clinical pharmacology 2021 10 78 (2): 215-225. Lyu Si-Qi, Zhu Jun, Wang Juan, Wu Shuang, Zhang Han, Shao Xing-Hui, Yang Yan-M |
| High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents. Translational stroke research 2021 10 13 (3): 391-398. Lv Huihui, Yang Zidong, Wu Haibo, Liu Mingyuan, Mao Xiaowei, Liu Xu, Ding Hongyan, Shi Zhuqing, Zhou Yang, Liu Qianyun, Zhang Yongkang, Zhou Yinting, Chen Kai, Li Zezhi, Dong Qiang, Ma Jianpeng, Han Y |
| Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV Patients. Antimicrobial agents and chemotherapy 2022 9 66 (10): e0227721. Sundell Jesper, Bienvenu Emile, Birgersson Sofia, Äbelö Angela, Ashton Micha |
| CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD). American heart journal 2022 8 254 141-148. Kranendonk J, Willems L H, Vijver-Coppen Rj van der, Coenen M, Adang E, Donders R, Zeebregts C J, Deneer Vhm, Reijnen Mmpj, Kramers C, Warlé M |
| Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review. European journal of clinical pharmacology 2022 6 78 (8): 1217-1225. Huang Shu, Yang Seonkyeong, Ly Shirly, Yoo Ryan H, Lo-Ciganic Wei-Hsuan, Eadon Michael T, Schleyer Titus, Whipple Elizabeth, Nguyen Khoa A |
| Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. Journal of the American Heart Association 2022 6 11 (12): e024709. Madan Mina, Abbott J Dawn, Lennon Ryan, So Derek Y F, MacDougall Andrea M, McLaughlin Mary Ann, Murthy Vishakantha, Saw Jacqueline, Rihal Charanjit, Farkouh Michael E, Pereira Naveen L, Goodman Shaun G, |
| Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation. Clinical pharmacology and therapeutics 2022 4 112 (1): 146-155. Thomas Cameron D, Franchi Francesco, Keeley Ellen C, Rossi Joseph S, Winget Marshall, David Anderson R, Dempsey Alyssa L, Gong Yan, Gower Megan N, Kerensky Richard A, Kulick Natasha, Malave Jean G, McDonough Caitrin W, Mulrenin Ian R, Starostik Petr, Beitelshees Amber L, Johnson Julie A, Stouffer George A, Winterstein Almut G, Angiolillo Dominick J, Lee Craig R, Cavallari Larisa |
| CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. Journal of the American Heart Association 2022 2 11 (4): e024159. Beitelshees Amber L, Thomas Cameron D, Empey Philip E, Stouffer George A, Angiolillo Dominick J, Franchi Francesco, Tuteja Sony, Limdi Nita A, Lee James C, Duarte Julio D, Kreutz Rolf P, Skaar Todd C, Coons James C, Giri Jay, McDonough Caitrin W, Rowland Rachel, Stevenson James M, Thai Thuy, Vesely Mark R, Wellen Jacob T, Johnson Julie A, Winterstein Almut G, Cavallari Larisa H, Lee Craig R, |
| Antiplatelet and myocardial protective effect of Shexiang Tongxin Dropping Pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of integrative medicine 2022 Jan . Lin Yan-Jun, Jiao Kun-Li, Liu Bo, Fang Lu, Meng S |
| CYP2C19 genotype and platelet aggregation test-guided dual antiplatelet therapy after off-pump coronary artery bypass grafting: A retrospective cohort study. Frontiers in cardiovascular medicine 2022 12 9 1023004. Yao Haoyi, Qin Kaijie, Liu Yun, Yang Yi, Zhu Jiaxi, Chen Anqing, Wang Zhe, Ye Xiaofeng, Zhou Mi, Li Haiqing, Qiu Jiapei, Zhao Qiang, Zhu Yunpe |
| Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovascular drugs and therapy 2022 11 . Mathew Roy O, Sidhu Mandeep S, Rihal Charanjit S, Lennon Ryan, El-Hajjar Mohammed, Yager Neil, Lyubarova Radmila, Abdul-Nour Khaled, Weitz Steven, O'Cochlain D Fearghas, Murthy Vishakantha, Levisay Justin, Marzo Kevin, Graham John, Dzavik Vlad, So Derek, Goodman Shaun, Rosenberg Yves D, Pereira Naveen, Farkouh Michael |
| Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. Pharmacogenomics 2022 1 23 (3): 207-220. Biswas Mohitosh, Sukasem Chonlaphat, Khatun Kali Most Sumaiya, Ibrahim Baharud |
| CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and translational science 2023 8 . Markus Ramste, Markus Ritvos, Sergei Häyrynen, Johanna I Kiiski, Mikko Niemi, Juha Sinisa |
| Association Between CYP2C19 Genotypes With Clinical Phenotypes and Adipokine Levels Among Ischemic Stroke Patients: A Prospective Observational Study. Cureus 2023 6 15 (5): e39265. Jitender Gairolla, Dheeraj Khurana, Phulen Sarma, Rupinder Kler, Bikash Medhi, Madhu Khullar, Manish Modi, Priyanka Naithani, Ashok Kum |
| The Evaluation of CYP2D6, CYP2C9, CYP2C19, and CYP2B6 Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics. Metabolites 2023 5 13 (5): . Arianna Giorgetti, Sara Amurri, Giulia Fazio, Carla Bini, Laura Anniballi, Filippo Pirani, Guido Pelletti, Susi Pelot |
| CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt. Journal of epidemiology and global health 2023 5 . Ahmed Shawky, Hussein Sabit, Mahmoud Nazih, Khalid Baraka, Mokhtar El-Zawah |
| Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC. Cardiovascular interventions 2023 4 16 (7): 829-843. Lee Seung Hun, Jeong Young-Hoon, Hong David, Choi Ki Hong, Lee Joo Myung, Park Taek Kyu, Yang Jeong Hoon, Hahn Joo-Yong, Choi Seung-Hyuck, Gwon Hyeon-Cheol, Jeong Myung Ho, Kim Byeong-Keuk, Joo Hyung Joon, Chang Kiyuk, Park Yongwhi, Ahn Sung Gyun, Suh Jung-Won, Lee Sang Yeub, Cho Jung Rae, Her Ae-Young, Kim Hyo-Soo, Kim Moo Hyun, Lim Do-Sun, Shin Eun-Seok, Song Young Bin, |
| Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center. Cureus 2023 3 15 (2): e34737. Kambhampati Nikhil Teja, Ahamed Hisham, K K Velayudhan, David Sachin, Hakeem Sai Chandra, Pillai Gopalakrishna, Kartha Nivedit |
| Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention. Circulation journal : official journal of the Japanese Circulation Society 2023 2 . Sawayama Yuichi, Tomita Yukinori, Kohyama Soji, Higo Yosuke, Kodama Kenji, Asada Kohei, Yagi Noriaki, Fukuyama Megumi, Hayashi Atsushi, Shioyama Wataru, Sakai Hiroshi, Ozawa Tomoya, Isono Tetsuichiro, Hira Daiki, Yamamoto Takashi, Morita Shin-Ya, Nakagawa Yoshihi |
| CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program. medRxiv : the preprint server for health sciences 2023 11 . Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, Kyung Min Lee, Zhenyu Lu, Julie A Lynch, Scott L DuVall, Jason L Vassy, Stephen W Waldo, John H Cleator, Thomas M Maddox, Daniel J Rader, Themistocles L Assimes, Scott M Damrauer, Philip S Tsao, Kyong-Mi Chang, Deepak Voora, Jay Giri, Sony Tute |
| Role of genetic polymorphisms in clopidogrel response variability: a systematic review. Open heart 2023 11 10 (2): . Jose Lopez, Justin Mark, Gustavo J Duarte, Mohammed Shaban, Franklin Sosa, Rishabh Mishra, Swati Jain, An Tran, Asma Khizar, Daniel Karpel, Giancarlo Acosta, Miguel Rodriguez-Guer |
| Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation. BMC medicine 2024 8 22 (1): 335. Ju Hyeon Kim, Soon Jun Hong, Jung-Joon Cha, Subin Lim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Tae Hoon Ahn, Young-Hoon Jeong, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun L |
| Comprehensive Analysis of Drug Utilization Patterns, Gender Disparities, Lifestyle Influences, and Genetic Factors: Insights from Elderly Cohort Using g-Nomic Software. Pharmaceuticals (Basel, Switzerland) 2024 5 17 (5): . Bárbara Rodríguez Castillo, Marc Cendrós, Carlos J Ciudad, Ana Sabat |
| Prognostic Impact of CYP2C19 Genotypes on Long-Term Clinical Outcomes in Older Patients After Percutaneous Coronary Intervention. Journal of the American Heart Association 2024 5 13 (10): e032248. Ju Hyeon Kim, Seung-Jun Lee, Jung-Joon Cha, Jae Hyoung Park, Soon Jun Hong, Tae Hoon Ahn, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Young-Hoon Jeong, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun Lim, |
| Genotype-Guided P2Y Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients: The CHAMP Trial - A Pilot Study and Safety Assessment. Mayo Clinic proceedings 2024 11 . Brenden S Ingraham, Samuel B Huxley, Conor M Lane, Rajiv Gulati, Bradley R Lewis, Allan S Jaffe, Malcolm R Bell, Amir Lerman, Naveen L Pereira, Ann M Moyer, Linnea M Baudhuin, Charanjit S Rihal, Mandeep Sin |
| Pharmacogenetics at scale in real-world bioresources: CYP2C19 and clopidogrel outcomes in UK Biobank. Pharmacogenetics and genomics 2024 1 . Khaled F Bedair, Blair Smith, Colin N A Palmer, Alex S F Doney, Ewan R Pears |
- Page last reviewed:Feb 1, 2024
- Content source: